National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 33720-33721 [2021-13527]

Download as PDF 33720 Federal Register / Vol. 86, No. 120 / Friday, June 25, 2021 / Notices lotter on DSK11XQN23PROD with NOTICES1 5:00 p.m. ET. For instructions, see below. Public Comments provided via Live Feedback Form during the meeting: No preregistration required. For instructions, see https://iacc.hhs.gov/meetings/iacc-meetings/ live-feedback.shtml. Contact Person: Ms. Rebecca Martin, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Bethesda, MD 20892– 9669, Phone: 301–435–9269, Email: IACCPublicInquiries@mail.nih.gov. Public Comments: The IACC welcomes public comments from members of the autism community. Comments may be submitted in writing via email to IACCPublicInquiries@ mail.nih.gov or using the web form at: https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 p.m. ET on Friday, July 2, 2021. Comments may be addressed to the Interagency Autism Coordinating Committee. A limited number of slots are available for individuals to provide a 2–3-minute summary or excerpt of their comment to the committee live during the virtual meeting using the virtual platform. For those interested in that opportunity, please indicate ‘‘Interested in providing virtual comment’’ in your written submission, along with your name, address, email, phone number, and professional/ organizational affiliation so that OARC staff can contact you if a slot is available for you to provide a summary or excerpt of your comment via the virtual platform during the meeting. For any given meeting, priority for virtual comment slots will be given to commenters who have not previously provided virtual comments in the current calendar year. This will help ensure that as many individuals as possible have an opportunity to share comments. Commenters going over their allotted 3-minute slot may be asked to conclude immediately to allow other comments and the rest of the meeting to proceed on schedule. Public comments received by 5:00 p.m. ET on Friday, July 2, 2021, will be provided to the Committee prior to the meeting for their consideration. Any written comments received after 5:00 p.m. ET, Friday, July 2, 2021, may be provided to the Committee either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. All public comments become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. For public comment VerDate Sep<11>2014 18:38 Jun 24, 2021 Jkt 253001 guidelines, see: https://iacc.hhs.gov/ meetings/public-comments/guidelines/. Individuals may also submit public comments to the IACC via a Live Feedback Form accessible from the webcast page on the days of the meeting during the time period announced. No pre-registration for Live Feedback comments is required. The link to the form will be accessible on the NIH Videocast website at https:// videocast.nih.gov and instructions are available on the IACC website: https:// iacc.hhs.gov/meetings/iacc-meetings/ live-feedback.shtml. This format is best suited for brief questions and comments for the committee. Submissions will be provided to the IACC and will become a part of the public record. Technical Issues: If you experience any technical problems with the webcast or conference call, please send an email to IACCPublicInquiries@ mail.nih.gov or use the Live Feedback form on the NIH Videocast meeting page. Meeting schedule subject to change. Disability Accommodations: All IACC Full Meetings provide Closed Captioning through the NIH videocast website. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the request. Special requests should be made at least seven (7) business days prior to the meeting; last minute requests may be made but may not be possible to accommodate. More Information: Information about the IACC is available on the website: https://www.iacc.hhs.gov. Dated: June 21, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–13528 Filed 6–24–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Outstanding Investigator Award (OIA)—R35. Date: August 4–5, 2021. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Kristen Page, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 827–7953, kristen.page@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze Enabling Technologies. Date: August 18, 2021. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 435–0297, goltrykl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Catalyze Product Definition. Date: August 19, 2021. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Kristin Goltry, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–B, Bethesda, MD 20892, (301) 435–0297, goltrykl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Early Stage Investigatory (EIA) R35 Review Meeting. Date: August 25, 2021. Time: 10:00 a.m. to 6:00 p.m. E:\FR\FM\25JNN1.SGM 25JNN1 Federal Register / Vol. 86, No. 120 / Friday, June 25, 2021 / Notices Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Tony L. Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 207–Q, Bethesda, MD 20892–7924, (301) 827–7913, creazzotl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: June 21, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–13527 Filed 6–24–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7037–N–02] 60-Day Notice of Proposed Information Collection: Comment Request; Housing Discrimination Claim Form HUD–903.1, HUD–903.1A, HUD–903.1B, HUD–903.1C, HUD–903.1F, HUD– 903.1CAM, HUD–903.1KOR, HUD– 903.1RUS, HUD–903–1_Somali; OMB Control No.: 2529–0011 Office of the Assistant Secretary for Fair Housing and Equal Opportunity, HUD. ACTION: Notice. AGENCY: The proposed reinstatement, with revised title and minor text revisions, of an expired, previously approved information collection for HUD Form Series HUD–903.1, HUD– 903.1A, HUD–903.1B, HUD–903.1C, HUD–903.1F, HUD–903.1CAM, HUD– 903.1KOR, HUD–903.1RUS, and HUD– 903–1_Somali will be submitted to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act of 1995. HUD is soliciting comments from all interested parties on the proposed reinstatement of this information collection. SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 DATES: Comment Due Date: August 24, 2021. Interested persons are invited to submit comments regarding the proposed reinstatement of this information collection. Comments should refer to the proposal by name and/or OMB Control Number, and ADDRESSES: VerDate Sep<11>2014 18:38 Jun 24, 2021 Jkt 253001 should be sent to Colette Pollard, Departmental Paperwork Reduction Act Officer, QMAC, U.S. Department of Housing and Urban Development, 451 7th Street SW, Room 4186, Washington, DC 20410–2000; telephone number (202) 402–3400 (this is not a toll-free number), or email at Colette.Pollard@ hud.gov for a copy of the proposed forms or other available information. Hearing or speech impaired individuals may access this number via TTY by calling the toll-free Federal Relay Service at: 1–(800) 877–8339. FOR FURTHER INFORMATION CONTACT: Erik A. Heins, Director, Enforcement Support Division, Office of Enforcement, U.S. Department of Housing and Urban Development, 451 7th Street SW, Room 5214, Washington, DC 20410–2000; telephone number (202) 402–5887 (this is not a toll-free number), or email at ERIK.A.HEINS@hud.gov. Hearing or speech impaired individuals may access this number via TTY by calling the tollfree Federal Relay Service at: 1–(800) 877–8339. SUPPLEMENTARY INFORMATION: HUD is submitting this proposed reinstatement, with revised title and minor text revisions, of an expired, previously approved information collection to the OMB for review, as required by the Paperwork Reduction Act of 1995 [44 U.S.C. Chapter 35, as amended]. HUD has revised the previous title of the HUD Form Series HUD–903.1 information collection from ‘‘Housing Discrimination Information Form’’ to ‘‘Housing Discrimination Claim Form (‘‘Form’’).’’ This revised title emphasizes that submitting a Housing Discrimination Claim Form to HUD is not equivalent to filing a jurisdictional housing discrimination complaint with HUD. The proposed minor text revisions comply with the procedures described in HUD’s Fair Housing Act regulation at 24 CFR part 103, subpart B, Subsections 103.10, 103.15, 103.20, 103.25, 103.30, 103.35, and 103.40. The revised Form also provides a complete list of mailing addresses, email addresses, and fax numbers for HUD’s ten (10) Regional Fair Housing and Equal Opportunity (FHEO) Offices. The proposed minor text revisions to HUD Form Series HUD–903.1 will not increase the information collection burden for aggrieved persons. Both the previous and revised Forms ask an aggrieved person to provide their full name; address; phone and/or email contact information; and alternative contact information. Both Forms also ask the aggrieved person to answer five (5) preliminary questions that may establish HUD’s authority (jurisdiction) PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 33721 to file and investigate a Fair Housing Act complaint. The proposed minor text revisions to HUD Form Series HUD–903.1 will not increase the total annual burden hours for aggrieved persons who submit the Form to HUD via the internet. Therefore, HUD does not believe that the time for completing the online version of the Form will exceed the current 45-minute time limit for internet submissions. This Notice is soliciting comments from members of the public and affected agencies concerning the proposed reinstatement, with revised title and minor text revisions, of an expired, previously approved collection of information concerning alleged discriminatory housing practices under the Fair Housing Act [42 U.S.C. 3601 et seq.]. The Fair Housing Act prohibits discrimination in the sale, rental, occupancy, advertising, and insuring of residential dwellings; and in residential real estate-related transactions; and in the provision of brokerage services, based on race, color, religion, sex, handicap [disability], familial status, or national origin. The Fair Housing Act also makes it unlawful to coerce, intimidate, threaten, or interfere with any person who has (1) exercised their fair housing rights; or (2) aided or encouraged another person to exercise their fair housing rights. Any person who claims to have been injured by a discriminatory housing practice, or any person who believes that they will be injured by a discriminatory housing practice that is about to occur, may file a complaint with HUD not later than one year after the alleged discriminatory housing practice occurred or terminated. HUD has designed Housing Discrimination Claim Form HUD–903.1 to promote consistency in the documents that, by statute, must be provided to persons against whom complaints are filed [‘‘respondents’’], and for the convenience of the general public. Section 103.25 of HUD’s Fair Housing Act regulation describes the information that must be included in each complaint filed with HUD. For purposes of meeting the Act’s one-year time limitation for filing complaints with HUD, complaints need not be initially submitted on the Form that HUD provides. Housing Discrimination Claim Form HUD–903.1 (English language), HUD–903.1A (Spanish language), HUD– 903.1B (Chinese language), HUD–903.1C (Arabic language), HUD–903.1F (Vietnamese language), HUD–903.1CAM (Cambodian language), HUD–903.1KOR (Korean language), HUD–903.1RUS (Russian language), and HUD–903– E:\FR\FM\25JNN1.SGM 25JNN1

Agencies

[Federal Register Volume 86, Number 120 (Friday, June 25, 2021)]
[Notices]
[Pages 33720-33721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13527]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Outstanding Investigator Award (OIA)--
R35.
    Date: August 4-5, 2021.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Kristen Page, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6705 Rockledge Drive, Room 
209-B, Bethesda, MD 20892, (301) 827-7953, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Catalyze Enabling Technologies.
    Date: August 18, 2021.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Kristin Goltry, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Catalyze Product Definition.
    Date: August 19, 2021.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Kristin Goltry, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Early Stage Investigatory (EIA) R35 Review 
Meeting.
    Date: August 25, 2021.
    Time: 10:00 a.m. to 6:00 p.m.

[[Page 33721]]

    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 207-Q, Bethesda, MD 20892-7924, (301) 827-7913, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-13527 Filed 6-24-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.